{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:55:12Z","timestamp":1788411312810,"version":"build-2803163510"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004095","name":"Kyowa Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Transgender women using feminizing gender-affirming hormone therapy who underwent a gonadectomy generally have lower testosterone levels than cisgender women. It is unknown if testosterone supplementation can influence subjective and genital sexual response in transgender women and whether this can be measured using vaginal photoplethysmography.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This study aimed to assess the feasibility of measuring changes in subjective and genital sexual response in transgender women who underwent a penile inversion vaginoplasty after testosterone supplementation to physiological female concentrations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Transgender women received daily testosterone 2% transdermal gel, aiming for serum concentrations between 1.5 and 2.5\u00a0nmol\/L for 12\u201320\u00a0weeks. Vaginal pulse amplitude (VPA) was measured during neutral, erotic fantasy, erotic film, and genital vibration stimulus blocks before and after testosterone supplementation. After each stimulus block, subjective sexual response was assessed. Sexual function, sexual excitability, and VPA measurement experience were assessed using questionnaires.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>Change in mean VPA score and subjective sexual response after testosterone supplementation during neutral film, erotic fantasy, erotic film, and genital vibration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Eight participants were included of whom seven completed the study. VPA during neutral film was significantly higher after testosterone supplementation [estimated ratio 2.7 (95% confidence interval {CI} 1.7\u20134.3), P\u2009&amp;lt;\u20090.001]. After testosterone supplementation, we observed no change in the degree of VPA response upon exposure to erotic fantasy [estimated ratio 1.4 (95% CI 0.68-2.8), P\u2009=\u20090.372], erotic film [estimated ratio 1.2 (95% CI 0.54\u20132.8), P\u2009=\u20090.629] and genital vibration [estimated ratio 1.2 (95% CI 0.46\u20132.9), P\u2009=\u20090.742] compared to before testosterone supplementation. After testosterone supplementation, participants reported significantly stronger feelings of sexual arousal, genital sensations, and positive affect in response to erotic fantasy and erotic film. Finally, there was a significant improvement in sexual function and sexual excitability assessed by questionnaires. VPA measurement was generally well-accepted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>Vaginal photoplethysmography can be used to assess changes in neovaginal perfusion in transgender women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths &amp; Limitations<\/jats:title>\n                  <jats:p>This is the first study assessing genital and subjective sexual response to testosterone supplementation in transgender women. The lack of a placebo condition precludes any clinical conclusions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Vaginal photoplethysmography can be used to assess changes in neovaginal vasocongestion after testosterone supplementation in transgender women. Explorative analyses suggest promising effects on subjective sexual response and an increase in general neovaginal perfusion. We found no difference in neovaginal vasocongestion after exposure to erotic stimuli before and after testosterone supplementation. Clinical benefit needs to be assessed in a blinded and placebo-controlled trial.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdaf041","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T11:56:08Z","timestamp":1742298968000},"page":"937-944","source":"Crossref","is-referenced-by-count":1,"title":["Exploring subjective and genital sexual response in transgender women upon addition of low-dose testosterone to feminizing gender-affirming hormone therapy: a feasibility study"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4922-9469","authenticated-orcid":false,"given":"Noor C","family":"Gieles","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Center of Expertise on Gender Dysphoria , Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, \u00a0","place":["The Netherlands"]},{"name":"Department of Medical Psychology, Center of Expertise on Gender Dysphoria , Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, \u00a0","place":["The Netherlands"]},{"name":"Amsterdam Public Health (APH) Research Institute, Amsterdam University Medical Center , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9713-4835","authenticated-orcid":false,"given":"Baudewijntje P C","family":"Kreukels","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology, Center of Expertise on Gender Dysphoria , Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, \u00a0","place":["The Netherlands"]},{"name":"Amsterdam Public Health (APH) Research Institute, Amsterdam University Medical Center , Amsterdam ,","place":["The Netherlands"]},{"name":"Amsterdam Reproduction and Development (AR&D) Research Institute, Amsterdam University Medical Center , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3620-5617","authenticated-orcid":false,"given":"Martin","family":"den Heijer","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Center of Expertise on Gender Dysphoria , Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, \u00a0","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7327-4940","authenticated-orcid":false,"given":"Stephanie","family":"Both","sequence":"additional","affiliation":[{"name":"Amsterdam Reproduction and Development (AR&D) Research Institute, Amsterdam University Medical Center , Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Sexology and Psychosomatic Gynecology and Obstetrics , Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Psychosomatic Gynecology and Sexology, Leiden University Medical Center , 2300 RC Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"8","key":"2025051303321952500_ref1","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.jsxm.2016.06.004","article-title":"Translational perspective on the role of testosterone in sexual function and dysfunction","volume":"13","author":"Podlasek","year":"2016","journal-title":"J Sex Med"},{"key":"2025051303321952500_ref2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.maturitas.2018.04.004","article-title":"Testosterone and sexual function in men","volume":"112","author":"Rastrelli","year":"2018","journal-title":"Maturitas"},{"issue":"4","key":"2025051303321952500_ref3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jsxm.2022.01.515","article-title":"Are endogenous androgens linked to female sexual function? A systemic review and meta-analysis","volume":"19","author":"Maseroli","year":"2022","journal-title":"J Sex Med"},{"issue":"12","key":"2025051303321952500_ref4","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S2213-8587(15)00284-3","article-title":"Testosterone in women\u2014the clinical significance","volume":"3","author":"Davis","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2025051303321952500_ref5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1677\/joe.1.06233","article-title":"The endocrinology of sexual arousal","volume":"186","author":"Bancroft","year":"2005","journal-title":"J Endocrinol"},{"issue":"2","key":"2025051303321952500_ref6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jsxm.2015.12.033","article-title":"Androgens and female sexual function and dysfunction--findings from the fourth international consultation of sexual medicine","volume":"13","author":"Davis","year":"2016","journal-title":"J Sex Med"},{"issue":"1","key":"2025051303321952500_ref7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/cmt.4.1.28.41","article-title":"The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women","volume":"4","author":"Laan","year":"2001","journal-title":"Climacteric"},{"issue":"2","key":"2025051303321952500_ref8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/archpsyc.57.2.149","article-title":"Time course of effects of testosterone administration on sexual arousal in women","volume":"57","author":"Tuiten","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"2025051303321952500_ref9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1743-6109.2006.00406.x","article-title":"Genital and subjective measurement of the time course effects of an acute dose of testosterone vs. placebo in postmenopausal women","volume":"4","author":"Heard-Davison","year":"2007","journal-title":"J Sex Med"},{"issue":"12","key":"2025051303321952500_ref10","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1007\/s40618-021-01598-1","article-title":"Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction","volume":"44","author":"Cipriani","year":"2021","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"2025051303321952500_ref11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.fertnstert.2016.10.028","article-title":"Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis","volume":"107","author":"Achilli","year":"2017","journal-title":"Fertil Steril"},{"issue":"4","key":"2025051303321952500_ref12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.mayocp.2017.11.002","article-title":"The international society for the study of women's sexual health process of care for management of hypoactive sexual desire disorder in women","volume":"93","author":"Clayton","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"2025051303321952500_ref13","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1210\/jc.2019-01603","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"104","author":"Davis","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025051303321952500_ref14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/13697137.2021.1891773","article-title":"International society for the study of women's sexual health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women","volume":"24","author":"Parish","year":"2021","journal-title":"Climacteric"},{"issue":"10","key":"2025051303321952500_ref15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S2213-8587(19)30189-5","article-title":"Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data","volume":"7","author":"Islam","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2025051303321952500_ref16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1210\/clinem\/dgac576","article-title":"Changes in serum testosterone and adrenal androgen levels in transgender women with and without gonadectomy","volume":"108","author":"Collet","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025051303321952500_ref17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1530\/EJE-07-0511","article-title":"Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels","volume":"158","author":"Elaut","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2025051303321952500_ref18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cca.2017.05.002","article-title":"Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS\/MS: impact of gender, age, oral contraceptives, body mass index and blood pressure status","volume":"470","author":"Eisenhofer","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2025051303321952500_ref19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"2","key":"2025051303321952500_ref20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/s0301-2115(01)00398-0","article-title":"Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels","volume":"99","author":"Serin","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"2025051303321952500_ref21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41585-018-0108-8","article-title":"Supporting sexuality and improving sexual function in transgender persons","volume":"16","author":"Holmberg","year":"2019","journal-title":"Nature Reviews Urology"},{"issue":"7","key":"2025051303321952500_ref22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41443-021-00409-8","article-title":"Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians","volume":"33","author":"Cocchetti","year":"2021","journal-title":"Int J Impot Res"},{"issue":"12","key":"2025051303321952500_ref23","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.jsxm.2019.09.003","article-title":"Prevalence of sexual dysfunctions in transgender persons: results from the ENIGI follow-up study","volume":"16","author":"Kerckhof","year":"2019","journal-title":"J Sex Med"},{"issue":"2","key":"2025051303321952500_ref24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10508-005-1792-z","article-title":"Measurement of sexual arousal in postoperative male-to-female transsexuals using vaginal photoplethysmography","volume":"34","author":"Lawrence","year":"2005","journal-title":"Arch Sex Behav"},{"issue":"2","key":"2025051303321952500_ref25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/EJE-09-0265","article-title":"Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study","volume":"161","author":"Kronawitter","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025051303321952500_ref26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/ejendo\/lvae103","article-title":"Addition of testosterone to endocrine care for transgender women: a dose-finding and feasibility trial","volume":"191","author":"Gieles","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025051303321952500_ref27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1469-8986.1995.tb02099.x","article-title":"Assessment of female sexual arousal: response specificity and construct validity","volume":"32","author":"Laan","year":"1995","journal-title":"Psychophysiology"},{"issue":"3","key":"2025051303321952500_ref28","doi-asserted-by":"publisher","first-page":"283.e1","DOI":"10.1016\/j.ajog.2018.07.012","article-title":"Sexual response in women with Mayer-Rokitansky-K\u00fcster-Hauser syndrome with a nonsurgical neovagina","volume":"219","author":"Both","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2025051303321952500_ref29","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s10508-015-0545-x","article-title":"Sexual response in women with type 1 diabetes mellitus: a controlled laboratory study measuring vaginal blood flow and subjective sexual arousal","volume":"44","author":"Both","year":"2015","journal-title":"Arch Sex Behav"},{"issue":"3","key":"2025051303321952500_ref30","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1525-1438.2007.01046.x","article-title":"Vaginal blood flow after radical hysterectomy with and without nerve sparing. A preliminary report","volume":"18","author":"Pieterse","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"2025051303321952500_ref31","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ejpain.2006.12.006","article-title":"The effect of pain-related fear on sexual arousal in women with superficial dyspareunia","volume":"11","author":"Brauer","year":"2007","journal-title":"Eur J Pain"},{"issue":"12","key":"2025051303321952500_ref32","doi-asserted-by":"publisher","first-page":"e0142575","DOI":"10.1371\/journal.pone.0142575","article-title":"Straight but not narrow; within-gender variation in the gender-specificity of women\u2019s sexual response","volume":"10","author":"Chivers","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"2025051303321952500_ref33","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1111\/j.1743-6109.2010.01833.x","article-title":"Genital and subjective sexual response in women after restorative proctocolectomy with ileal pouch anal anastomosis--a prospective clinical trial","volume":"7","author":"Vlug","year":"2010","journal-title":"J Sex Med"},{"issue":"1","key":"2025051303321952500_ref34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/00926230500232909","article-title":"Reliability and construct validity of the changes in sexual functioning questionnaire short-form (CSFQ-14)","volume":"32","author":"Keller","year":"2006","journal-title":"J Sex Marital Ther"},{"key":"2025051303321952500_ref35","first-page":"77","volume-title":"Handbook of Sexuality-Related Measures","author":"Janssen","year":"2020","edition":"4th"},{"key":"2025051303321952500_ref36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cca.2016.01.002","article-title":"Comparison of eight routine unpublished LC-MS\/MS methods for the simultaneous measurement of testosterone and androstenedione in serum","volume":"454","author":"B\u00fcttler","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"6","key":"2025051303321952500_ref37","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1515\/cclm-2023-1138","article-title":"Report from the HarmoSter study: different LC-MS\/MS androstenedione, DHEAS and testosterone methods compare well; however, unifying calibration is a double-edged sword","volume":"62","author":"Fanelli","year":"2024","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"2025051303321952500_ref38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.contraception.2018.02.014","article-title":"Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II randomized, double-blind, placebo-controlled study","volume":"98","author":"van Lunsen","year":"2018","journal-title":"Contraception"},{"issue":"3","key":"2025051303321952500_ref39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.sxmr.2020.03.003","article-title":"Testosterone and vaginal function","volume":"8","author":"Maseroli","year":"2020","journal-title":"Sex Med Rev"},{"issue":"4","key":"2025051303321952500_ref40","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.sxmr.2018.03.005","article-title":"Role of androgens in female genitourinary tissue structure and function: implications in the genitourinary syndrome of menopause","volume":"6","author":"Traish","year":"2018","journal-title":"Sex Med Rev."},{"issue":"1","key":"2025051303321952500_ref41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/andro.2021.0033","article-title":"The impact of testosterone on erectile function","volume":"3","author":"Schardein","year":"2022","journal-title":"Androg Clin Res Ther"},{"key":"2025051303321952500_ref42","doi-asserted-by":"publisher","first-page":"102297","DOI":"10.1016\/j.bpobgyn.2022.102297","article-title":"Genital gender-affirming surgery for transgender women","volume":"86","author":"van der Sluis","year":"2023","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"2025051303321952500_ref43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1743-6109.2008.01142.x","article-title":"The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction","volume":"6","author":"van der Made","year":"2009","journal-title":"J Sex Med"},{"issue":"1","key":"2025051303321952500_ref44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.sxmr.2021.04.001","article-title":"Sexual functioning of transgender females post-vaginoplasty: evaluation, outcomes and treatment strategies for sexual dysfunction","volume":"10","author":"Schardein","year":"2021","journal-title":"Sex Med Rev"},{"issue":"6","key":"2025051303321952500_ref45","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/00224499.2021.2004384","article-title":"Resisting trans medicalization: body satisfaction and social contextual factors as predictors of sexual experiences among trans feminine and nonbinary individuals","volume":"60","author":"Goldbach","year":"2022","journal-title":"J Sex Res"},{"issue":"1","key":"2025051303321952500_ref46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3138\/cjhs.24.1-CO1","article-title":"Toward a broader conceptualization of trans women's sexual health","volume":"24","author":"Bauer","year":"2015","journal-title":"Can J Hum Sex"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/5\/937\/62441873\/qdaf041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/5\/937\/62441873\/qdaf041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:32:25Z","timestamp":1747121545000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/22\/5\/937\/8084714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3,18]]},"published-print":{"date-parts":[[2025,5,10]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdaf041","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,3,18]]}}}